Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase by switching to lower-cost plans.
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase by switching to lower-cost plans.
<iframe src="https://statesidedaily.com/embed/cluster/5792e4a222352a6863001cd4c7e4583f6da6a86f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices"></iframe>
